Omer Munshi, MD
Pain Medicine · Houston, TXNPI 1790913739
Payments from drug & device makers
Across 35 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$172
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$84
- Johnson & Johnson$74
- Stryker$71
- Nevro Corp.$57
- Collegium Pharmaceutical, Inc.$45
- plus $253 from 10 others
What the payments were for
- Food & beverage$756100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $172 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Johnson & Johnson | 5 | $74 |
| Stryker | 2 | $71 |
| Nevro Corp. | 2 | $57 |
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| Medtronic | 2 | $37 |
| Globus Medical | 1 | $37 |
| Stimwave Technologies Incorporated | 1 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Almatica Pharma LLC | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| Sobi, Inc | 1 | $14 |
How this compares
$756 in reported general payments places this provider in the 25th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 209 | $1,818 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 194 | $1,594 |
| Gabapentin | 103 | $1,479 |
| Lidocaine | 16 | $1,186 |
| Pregabalin | 75 | $1,103 |
| Tramadol Hcl | 180 | $1,024 |
| Ketorolac Tromethamine | 58 | $864 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $766 |
| Tizanidine Hcl | 57 | $750 |
| Methylprednisolone | 80 | $613 |
| Diclofenac Sodium | 22 | $268 |
| Methocarbamol | 39 | $242 |
| Meloxicam | 54 | $172 |
| Hydroxyzine Hcl | 11 | $163 |
| Baclofen | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Houston
- Mitchell EngleHouston$1.5M
- Daniel PakHouston$460K
- David LeimanHouston$281K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$161K
- Mayur KanjiaHouston$46K
- Baominh VinhHouston$44K
- Matthew ChungHouston$26K
- Aaron CalodneyTyler$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.